GeoVax Labs, Inc.
GOVX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $1 | $2 | $1 |
| % Growth | -100% | -47.9% | 89.4% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | -$0 | $1 | $2 | $1 |
| % Margin | – | 100% | 99% | 97.5% |
| R&D Expenses | $5 | $5 | $5 | $8 |
| G&A Expenses | $0 | $2 | $0 | $0 |
| SG&A Expenses | $1 | $2 | $2 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $6 | $6 | $7 | $9 |
| Operating Income | -$6 | -$5 | -$5 | -$8 |
| % Margin | – | -635.8% | -330.2% | -965.3% |
| Other Income/Exp. Net | $0 | $0 | $0 | $0 |
| Pre-Tax Income | -$6 | -$5 | -$5 | -$8 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$6 | -$5 | -$5 | -$8 |
| % Margin | – | -630% | -327.3% | -955.9% |
| EPS | -0.31 | -0.35 | -0.45 | -0.78 |
| % Growth | 11.4% | 22.2% | 42.3% | – |
| EPS Diluted | -0.31 | -0.35 | -0.45 | -0.78 |
| Weighted Avg Shares Out | 20 | 15 | 12 | 11 |
| Weighted Avg Shares Out Dil | 20 | 15 | 12 | 11 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$6 | -$5 | -$5 | -$8 |
| % Margin | – | -628.1% | -326.3% | -953.4% |